Insider · CIK 0001878075

Niklason Laura E

Reports to the SEC for 1 company · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001878075

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+80K sh	—	—	80,000
2025-11-16	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+311K sh	—	—	311,100
2025-08-20	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−592K sh	$1.58	−$935K	0
2025-08-19	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−1.1M sh	$1.63	−$1.79M	591,685
2025-08-18	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−549K sh	$1.83	−$1.01M	1,691,685
2025-06-12	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	0 sh	—	—	0
2025-01-21	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+1.13M sh	—	—	1,130,311
2024-12-19	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+525 sh	—	—	2,625
2024-11-20	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−261K sh	$4.40	−$1.15M	1,730,884
2024-11-19	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−427K sh	$4.34	−$1.86M	1,992,253
2024-11-19	HUMAHumacyte, Inc.P Purchase	Director, President, CEO and Director	PPurchase	+1,797 sh	$4.44	+$7,978.68	243,851
2024-11-18	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−811K sh	$4.44	−$3.6M	2,419,712
2024-09-10	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−289K sh	$5.23	−$1.51M	3,230,884
2024-09-09	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−158K sh	$5.42	−$855K	3,519,558
2024-08-29	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−352K sh	$6.35	−$2.24M	3,677,262
2024-08-29	HUMAHumacyte, Inc.P Purchase	Director, President, CEO and Director	PPurchase	+1,222 sh	$6.54	+$7,997.99	242,054
2024-08-28	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−277K sh	$6.47	−$1.79M	4,029,374
2024-08-27	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−253K sh	$6.71	−$1.7M	4,306,464
2024-06-13	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+50K sh	—	—	50,000
2024-06-12	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−272K sh	$7.30	−$1.98M	4,559,140
2024-06-11	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−282K sh	$7.09	−$2M	4,907,288
2024-06-11	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−76.6K sh	$7.02	−$538K	4,830,658
2024-06-04	HUMAHumacyte, Inc.P Purchase	Director, President, CEO and Director	PPurchase	+2,362 sh	$6.35	+$15K	240,832
2024-06-04	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−1,852 sh	$7.28	−$13.5K	5,189,288
2024-06-03	HUMAHumacyte, Inc.P Purchase	Director, President, CEO and Director	PPurchase	+2,050 sh	$7.37	+$15.1K	238,470
2024-06-03	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−190K sh	$7.42	−$1.41M	5,191,140
2024-05-31	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−717K sh	$7.78	−$5.57M	5,474,567
2024-05-31	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−93.2K sh	$8.93	−$832K	5,381,354
2023-12-11	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+525 sh	—	—	2,100
2023-12-08	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+803K sh	—	—	803,000
2023-10-10	HUMAHumacyte, Inc.M Exercise/Conversion	Director, President, CEO and Director	MExercise/Conversion	+114K sh	$1.19	+$136K	1,384,660
2023-10-10	HUMAHumacyte, Inc. · Stock Options (right to buy)M Exercise/Conversion	Director, President, CEO and Director	MExercise/Conversion	−114K sh	—	—	48,176
2023-09-14	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−2M sh	$2.78	−$5.56M	6,191,140
2023-08-21	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−602K sh	$3.39	−$2.04M	8,191,140
2023-08-18	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−627K sh	$3.57	−$2.24M	8,793,583
2023-08-17	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−570K sh	$3.68	−$2.1M	9,420,562
2023-06-15	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−500K sh	$3.12	−$1.56M	9,990,736
2023-06-15	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+8,500 sh	—	—	8,500
2023-06-13	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−4.88M sh	$2.60	−$12.7M	10,490,736
2023-05-25	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−2.63M sh	$2.75	−$7.22M	15,365,736
2023-03-01	HUMAHumacyte, Inc.M Exercise/Conversion	Director, President, CEO and Director	MExercise/Conversion	+100K sh	$1.19	+$119K	1,270,240
2023-03-01	HUMAHumacyte, Inc. · Stock Options (right to buy)M Exercise/Conversion	Director, President, CEO and Director	MExercise/Conversion	−100K sh	—	—	162,596
2022-12-16	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−240K sh	$2.53	−$606K	17,990,736
2022-12-15	HUMAHumacyte, Inc.P Purchase	Director, President, CEO and Director	PPurchase	+10K sh	$2.54	+$25.4K	1,170,240
2022-12-15	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−93.4K sh	$2.63	−$246K	18,230,274
2022-12-14	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−276K sh	$2.76	−$763K	18,323,700
2022-12-13	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−330K sh	$2.84	−$937K	18,600,004
2022-12-08	HUMAHumacyte, Inc. · Stock Options (right to buy)A Award	Director, President, CEO and Director	AAward	+445K sh	—	—	444,500
2022-09-15	HUMAHumacyte, Inc.S Sale	Director, President, CEO and Director	SSale	−1.52M sh	$4.00	−$6.09M	18,930,004
2022-09-15	HUMAHumacyte, Inc.P Purchase	Director, President, CEO and Director	PPurchase	+2,000 sh	$4.14	+$8,280	1,160,240

Recent filings

Accepted (ET)
Jun 124
Niklason Laura E0001104659-26-073615
SEC(opens sec.gov)
Nov 174
Niklason Laura E0001628280-25-052715
SEC(opens sec.gov)
Aug 204
Niklason Laura E0001104659-25-081008
SEC(opens sec.gov)
Jun 164
Niklason Laura E0001818382-25-000113
SEC(opens sec.gov)
Jan 234
Niklason Laura E0001818382-25-000017
SEC(opens sec.gov)
Dec 204
Niklason Laura E0001818382-24-000231
SEC(opens sec.gov)
Nov 214
Niklason Laura E0001818382-24-000214
SEC(opens sec.gov)
Nov 204
Niklason Laura E0001818382-24-000208
SEC(opens sec.gov)
Sep 114
Niklason Laura E0001818382-24-000184
SEC(opens sec.gov)
Sep 34
Niklason Laura E0001818382-24-000177
SEC(opens sec.gov)
Aug 294
Niklason Laura E0001818382-24-000166
SEC(opens sec.gov)
Jun 174
Niklason Laura E0001818382-24-000138
SEC(opens sec.gov)
Jun 134
Niklason Laura E0001818382-24-000101
SEC(opens sec.gov)

Companies

Humacyte, Inc.Director, President, CEO and DirectorHUMA

Address

2525 EAST NORTH CAROLINA HIGHWAY 54

DURHAM, NC, 27713